FDA NDC Directory · JSON-LD · Markdown

Sodium Thiosulfate

NDC 60267-705 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHope Pharmaceuticals
Marketing categoryNew Drug Application (innovator) · App NDA203923
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsSODIUM THIOSULFATE (250 mg/mL)
Marketing started20120214
Package count1

External sources

Source: openFDA. Public-domain (CC0).